OpenAI chief Sam Altman outlined two catastrophic risks facing artificial intelligence development on Monday, warning that labs could lose control of future systems or watch power concentrate dangerously among a single company or individual. According to posts on X, Altman’s detailed safety frameworks arrived just days after he joined Anthropic’s Dario Amodei and Elon Musk in calling for an industry-wide development slowdown.
Altman Outlines Safety Frameworks and Frontier Pacing
Altman stated on X that his company welcomes a federal framework establishing consistent safety requirements for frontier AI, emphasizing that competitive pressure from the United States should not excuse recklessness. According to Altman, pacing development does not mean stopping it entirely. Progress remains rapid, but capabilities must not outrun alignment and monitoring. Altman also endorsed independent evaluators with employee-like access, a proposal initially put forward by Anthropic.
Amodei’s Three-Step Proposal to Curb Recursive Self-Improvement
Safety concerns escalated sharply after an Anthropic researcher resigned, warning that those building it believed advanced systems could “kill us all by the end of the decade.” According to Dario Amodei, artificial intelligence has advanced drastically faster since the summer due to recursive self-improvement, where systems build subsequent generations of AI. Amodei proposed a three-step plan involving external employee-like access, common safety standards across frontier labs, and global coordination to limit unchecked progress without sacrificing the United States’ lead in AI.
Did you know? Artificial intelligence stocks dropped on Monday as investors digested the comments.
White House Pushback and International Tensions
U.S. President Donald Trump dismissed the CEOs’ warning on Sunday, asserting that a slowdown was unnecessary and would jeopardize American leadership over China. Meanwhile, international coordination faces steep hurdles. Amodei noted during an interview with CBS News’ “Sunday Morning” that adversarial nations might not adopt similar speed limits due to military advantages. Chinese state-owned media outlet Global Times criticized Amodei’s proposals on Monday, arguing that the framework seeks to portray China’s legitimate development as a threat and fuel confrontation between China and the US, while China’s Foreign Ministry dismissed the executives’ remarks as fearmongering.
Frequently Asked Questions
Why are AI lab executives calling for a slowdown?
According to Dario Amodei, rapid advancements in recursive self-improvement risk outpacing human ability to understand and control these systems, prompting fears of catastrophic risks.
What did Sam Altman propose regarding safety?
Altman endorsed federal safety frameworks, independent auditors with employee-like access, and pacing the frontier to ensure alignment keeps pace with capabilities.
How has the U.S. government responded to the proposed slowdown?
President Donald Trump rejected the need for a slowdown, stating it would threaten America’s lead in artificial intelligence against China.
Join the Conversation
What are your thoughts on balancing artificial intelligence safety frameworks with global competitiveness? Share your perspective in the comments below, or subscribe to our newsletter for ongoing updates on technology policy.
Worth a look
- Censys Debuts at GISEC Global 2026 for Internet Intelligence and Exposure Management
- Putin Uninterested in Energy Ceasefire
- Breakthrough Salk Study Uncovers Mechanism Behind Immunotherapy Resistance: Interferons, Mitochondrial Dysfunction, and PGE2″ Interferons, mitochondrial dysfunction and PGE2: Salk study reveals mechanism behind immunotherapy resistance. Boost its search engine visibility with relevant keywords for maximum impact. Immunotherapy resistance remains one of the biggest hurdles in cancer treatment. According to a recent study published in the journal Nature Communications, scientists at the Salk Institute have made a groundbreaking discovery that sheds light on the underlying mechanisms behind this resistance. The study reveals that interferons, a type of protein that plays a crucial role in the immune system, can contribute to mitochondrial dysfunction in cancer cells. This dysfunction can lead to the production of prostaglandin E2 (PGE2), a molecule that promotes tumor growth and resistance to immunotherapy. In their study, the researchers found that PGE2 production was a key factor in the development of immunotherapy resistance in cancer cells. The team used a combination of experimental and computational models to investigate the relationship between interferons, mitochondrial dysfunction, and PGE2 production. The findings of the study suggest that targeting PGE2 production could be a potential strategy for overcoming immunotherapy resistance. The researchers propose that blocking PGE2 receptors or inhibiting its production could help restore the function of mitochondria in cancer cells, making them more susceptible to immunotherapy. The study’s authors hope that their findings will pave the way for the development of new therapies that can overcome immunotherapy resistance and improve treatment outcomes for cancer patients. Key Takeaways: – Interferons contribute to mitochondrial dysfunction in cancer cells – Mitochondrial dysfunction leads to PGE2 production, promoting tumor growth and resistance to immunotherapy – Targeting PGE2 production could be a potential strategy for overcoming immunotherapy resistance – Restoring mitochondrial function in cancer cells could make them more susceptible to immunotherapy Keywords: immunotherapy resistance, interferons, mitochondrial dysfunction, PGE2, Salk Institute, cancer treatment, breakthrough study, Nature Communications. (archyworldys.com)